Telix Pharmaceuticals(AU:TLX)
A$13.58-0.12 (-0.88%)
AU:TLX
Telix Pharmaceuticals stock drug pipeline
A$13.58
At close:-0.12 (-0.88%)
Want to see AU:TLX full AI Analyst Report?
Telix Pharmaceuticals (TLX) Drug Pipeline
654 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| 89Zr-Dfosq-Olaratumab | Soft Tissue Sarcoma, Pdgfr Alpha Positive Solid Tumours | Phase I | Recruiting | 89Zr-olaratumab Dosimetry in Participants With PDGFR Alpha Positive Solid Tumours and Soft Tissue Sarcoma | Apr 29, 2024 | ― |
| Standard Of Care, 177Lu-Dota-Rosopatamb | Metastatic Prostate Cancer | Phase III | Terminated | The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only | May 03, 2021 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| 89Zr-Dfosq-Olaratumab | Phase I | Soft Tissue Sarcoma, Pdgfr Alpha Positive Solid Tumours | Recruiting | 89Zr-olaratumab Dosimetry in Participants With PDGFR Alpha Positive Solid Tumours and Soft Tissue Sarcoma | Apr 29, 2024 | ― |
| Standard Of Care, 177Lu-Dota-Rosopatamb | Phase III | Metastatic Prostate Cancer | Terminated | The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only | May 03, 2021 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Telix Pharmaceuticals Ltd. (AU:TLX) have in its pipeline
Telix Pharmaceuticals AU:TLX is currently developing the following drugs: 89Zr-Dfosq-Olaratumab, Standard Of Care, 177Lu-Dota-Rosopatamb. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
